Related Experiment Video
Updated: Nov 17, 2025

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
On the emergence, spread and resistance of Candida auris: host, pathogen and environmental tipping points
Arunaloke Chakrabarti1, Prashant Sood1
1Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Abstract:
Over a decade ago, a multidrug-resistant nosocomial fungus Candida auris emerged worldwide and has since become a significant challenge for clinicians and microbiologists across the globe. A resilient pathogen, C. auris survives harsh disinfectants, desiccation and high-saline environments. It readily colonizes the inanimate environment, susceptible patients and causes invasive infections that exact a high toll. Prone to misidentification by conventional microbiology techniques, C. auris rapidly acquires multiple genetic determinants that confer multidrug resistance. Whole-genome sequencing has identified four distinct clades of C. auris, and possibly a fifth one, in circulation. Even as our understanding of this formidable pathogen grows, the nearly simultaneous emergence of its distinct clades in different parts of the world, followed by their rapid global spread, remains largely unexplained. We contend that certain host-pathogen-environmental factors have been evolving along adverse trajectories for the last few decades, especially in regions where C. auris originally appeared, until these factors possibly reached a tipping point to compel the evolution, emergence and spread of C. auris. Comparative genomics has helped identify several resistance mechanisms in C. auris that are analogous to those seen in other Candida species, but they fail to fully explain how high-level resistance rapidly develops in this yeast. A better understanding of these unresolved aspects is essential not only for the effective management of C. auris patients, hospital outbreaks and its global spread but also for forecasting and tackling novel resistant pathogens that might emerge in the future. In this review, we discuss the emergence, spread and resistance of C. auris, and propose future investigations to tackle this resilient pathogen.
Insights
The multidrug-resistant fungus Candida auris emerged globally, posing a significant clinical challenge due to its resilience and rapid spread. Understanding its evolution and resistance mechanisms is crucial for effective management and future pathogen preparedness.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Genomics
Background:
- Candida auris is a multidrug-resistant, nosocomial fungus that emerged globally over a decade ago.
- It is a resilient pathogen, capable of surviving harsh environments and readily colonizing surfaces and patients, leading to invasive infections.
- C. auris is prone to misidentification and rapidly acquires multidrug resistance, presenting a significant challenge to clinicians and microbiologists.
Purpose of the Study:
- To review the emergence, spread, and resistance of Candida auris.
- To explore the unexplained simultaneous emergence and global spread of distinct C. auris clades.
- To propose future research directions for understanding and tackling this resilient pathogen.
Main Methods:
- Review of existing literature on Candida auris.
- Analysis of whole-genome sequencing data to identify distinct clades.
- Comparative genomics to identify resistance mechanisms.
Main Results:
- Whole-genome sequencing identified four to five distinct clades of C. auris in circulation.
- Comparative genomics revealed resistance mechanisms analogous to other Candida species, but these do not fully explain the rapid development of high-level resistance in C. auris.
- The simultaneous emergence and rapid global spread of distinct clades remain largely unexplained, possibly due to evolving host-pathogen-environmental factors reaching a tipping point.
Conclusions:
- A deeper understanding of C. auris's evolution, resistance, and spread is essential for patient management and outbreak control.
- Investigating the interplay of host, pathogen, and environmental factors is crucial for explaining its emergence and spread.
- Future research should focus on unresolved aspects of C. auris resistance and spread to prepare for novel resistant pathogens.
Related Concept Videos
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Gene Regulation in Microbial Communities: Quorum Sensing
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Development of Antibiotic Resistance

